Isabelle Moses*
The COVID-19 and Cancer Global Modeling Consortium (CCGMC) was established in May 2020 to address the global need for evidence regarding the impact of interruptions and their moderation. The CCGMC intends to organise pertinent research on COVID-19 and disease and set up illuminating demonstrating stages for malignant growth control decision-production. Three interconnected work streams have been established by the CCGMC to examine the impact of COVID-19 on the outcomes of malignant growth screening and analysis, and disease risk. The focus is on developing a framework that will allow for the distribution of regularly updated short- and long-term projections of malignant growth significant outcomes. A lot of attention is being paid to evaluating potential prioritisation and recovery strategies both during and after the serious social and wellbeing administration interruptions experienced globally.
English 
Spanish 
Chinese 
German 
French 
Japanese 
Portuguese 
Hindi